Group 1 - The markets are experiencing a continuous rally, reaching new highs despite challenges in the jobs market, housing sector, and consumer sentiment [2] - Moody's Analytics has indicated a rising chance of recession in the United States within the next 12 months [2] - The Biotech Forum offers a model portfolio featuring 12-20 high upside biotech stocks, along with live discussions and weekly market commentary [2]

Group 1 - The U.S. economy is currently driven by two main factors: significant fiscal deficit spending, which has been between 6% and 7% of GDP in recent years [1] Group 2 - The Biotech Forum offers a model portfolio consisting of 12-20 high upside biotech stocks, along with live chat discussions on trade ideas and weekly market commentary [1]

Group 1 - The second quarter earnings season has revealed that tariffs are increasingly affecting many companies' bottom lines [1] - Companies have been able to navigate some of the impacts of tariffs thus far [1] Group 2 - A small covered call position in ANF was taken during a significant market sell-off in early April due to the announcement of reciprocal tariffs [3]